Nir Sassi
Vermögen: 47 094 $ am 31.05.2026
Vermögen: 47 094 $ am 31.05.2026
Nir Sassi worked as Senior Manager at PricewaterhouseCoopers (Israel) from 2002 to 2010.
Served as Chief Financial Officer at Intec Pharma Ltd. from 2016 to 2021.
Served as Chief Financial Officer at Indaptus Therapeutics, Inc. from 2021 to 2023.
Completed undergraduate studies at Ben-Gurion University of the Negev.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 22.12.2025 | 26.758 ( 0,02 % ) | 47 094 $ | 31.05.2026 |
| Unternehmen | Position | Ende |
|---|---|---|
| INDAPTUS THERAPEUTICS, INC. | Finanzdirektor/CFO | 01.04.2026 |
PricewaterhouseCoopers (Israel)
PricewaterhouseCoopers (Israel) Miscellaneous Commercial ServicesCommercial Services Provides legal services | Corporate Officer/Principal | 01.01.2010 |
Intec Pharma Ltd.
Intec Pharma Ltd. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products to treat neurodegenerative diseases | Finanzdirektor/CFO | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 4 |
|---|---|
PricewaterhouseCoopers (Israel)
PricewaterhouseCoopers (Israel) Miscellaneous Commercial ServicesCommercial Services Provides legal services | Commercial Services |
Ben-Gurion University of the Negev
Ben-Gurion University of the Negev Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Intec Pharma Ltd.
Intec Pharma Ltd. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products to treat neurodegenerative diseases | Health Technology |
Indaptus Therapeutics, Inc.
Indaptus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen